![]() |
市场调查报告书
商品编码
1775455
医疗辐射屏蔽市场:2025-2030 年预测Medical Radiation Shielding Market - Forecasts from 2025 to 2030 |
医疗辐射屏蔽市场预计将从 2025 年的 13.4 亿美元成长到 2030 年的 17.21 亿美元,复合年增长率为 5.14%。
慢性病盛行率上升
慢性疾病(尤其是癌症)的日益普及是医疗辐射屏蔽市场的主要驱动力。根据美国卫生研究院的数据,预计到2024年,光在美国就将诊断出2,001,140例新发癌症病例,导致611,720人死亡。在全球范围内,癌症仍然是主要的死亡原因,因此需要先进的诊断成像和放射治疗。 X光、 电脑断层扫描和放射治疗等程序需要强大的屏蔽来保护患者和医护人员免受有害电离辐射的伤害,这推动了对屏蔽材料和解决方案的需求。
诊断影像和放射治疗的成长
诊断影像中心和放射治疗设施的扩张正在推动市场成长。根据美国核子医学会 (美国 Society of Nuclear Medicine) 的报告,对早期疾病检测和预防保健的重视,导緻美国每年进行包括核子医学在内的诊断影像程序的数量增加到近 2,000 万次。 X 光、CT、MRI 和放射治疗等诊断和治疗应用的激增需要先进的屏蔽解决方案,以确保医院、诊断中心以及牙科和兽医诊所等专科机构的安全。
医护人员的健康风险
慢性低剂量辐射暴露对医护人员的健康构成重大风险,包括增加脑肿瘤、皮肤癌、甲状腺癌、乳癌、黑色素瘤、白内障、中风、动脉硬化症和认知障碍的发生率。传统的铅罩衣虽然有效,但体积庞大,会给医生带来身体压力,尤其是下背部疼痛。头部和眼睛等未受防护的部位会增加脑肿瘤和白内障的风险。这些担忧促使人们寻求轻便、有效的防护解决方案,以提高职业安全。
技术创新
市场参与者正在透过创新的屏蔽解决方案来应对安全挑战。 2023 年,SDS Specialist Door Solutions 推出了专为医疗机构设计的 Shieldoor 铅衬 X 光门,为放射治疗机构提供可客製化的辐射防护。 2023 年 4 月,Million Technologies 收购了 PTW Dosimetry,增强了其辐射屏蔽和监测系统产品组合。 Radiaction Medical Ltd. 的 Shield System 于 2023 年 4 月获得 FDA 510(k) 许可,并获得 1000 万美元用于在美国推出这种创新的辐射防护解决方案并在欧洲扩展。在印度,先进材料和製程研究所 (CSIR-AMPRI) 开发了无铅辐射屏蔽瓦,并获得了原子能美国核能管理委员会的批准。到 2024 年,马哈拉斯特拉邦Saideep 医院的 X 光室、 电脑断层扫描室和心导管室将安装 2600 块屏蔽瓦。此外,MXR Imaging 于 2023 年 8 月收购了 Spartan Shield,增强了其 MRI 套件的射频、磁场和辐射防护能力。这些进步,包括钨和铋合金等无铅材料的采用,反映了公司向更安全、更轻、更环保的屏蔽解决方案的转变。
The Medical Radiation Shielding Market is expected to grow from USD 1.340 billion in 2025 to USD 1.721 billion in 2030, at a CAGR of 5.14%.
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, particularly cancer, is a primary driver of the medical radiation shielding market. In 2024, an estimated 2,001,140 new cancer cases were diagnosed in the United States alone, with 611,720 deaths, according to the National Institutes of Health. Globally, cancer remains a leading cause of mortality, necessitating advanced diagnostic imaging and radiation therapy. Procedures such as X-rays, CT scans, and radiation therapy require robust shielding to protect patients and healthcare workers from harmful ionizing radiation, driving demand for shielding materials and solutions.
Growing Diagnostic Imaging and Radiation Therapy
The expansion of diagnostic imaging centers and radiation therapy facilities is fueling market growth. The emphasis on early disease detection and preventive healthcare has increased the number of imaging procedures, including nearly 20 million nuclear medicine procedures performed annually in the U.S., as reported by the Society of Nuclear Medicine. This surge in diagnostic and therapeutic applications, including X-ray, CT, MRI, and radiation therapy, necessitates advanced shielding solutions to ensure safety in hospitals, diagnostic centers, and specialized facilities like dental and veterinary clinics.
Health Risks to Medical Professionals
Chronic low-dose radiation exposure poses significant health risks to medical staff, including increased incidences of brain, skin, thyroid, and breast cancers, melanomas, cataracts, strokes, atherosclerotic disease, and cognitive impairments. Traditional lead gowns, while effective, are bulky and cause physical strain, particularly back pain, among physicians. Unshielded areas, such as the head and eyes, heighten risks of brain tumors and cataracts. These concerns are driving innovation in lightweight, effective shielding solutions to enhance occupational safety.
Technological Innovations
Market players are addressing safety challenges through innovative shielding solutions. In 2023, SDS Specialist Door Solutions launched Shieldoor lead-lined X-ray doors, designed for healthcare settings to provide customizable radiation protection in radiology facilities. In April 2023, Mirion Technologies acquired PTW Dosimetry, enhancing its portfolio of radiation shielding and monitoring systems. Radiaction Medical Ltd. received FDA 510(k) clearance in April 2023 for its Shield System, securing USD 10 million to launch this innovative radiation protection solution in the U.S. and expand in Europe. In India, the Advanced Materials and Processes Research Institute (CSIR-AMPRI) developed lead-free radiation shielding tiles, approved by the Atomic Energy Regulatory Board, with 2,600 tiles installed at Saideep Hospital in Maharashtra for X-ray rooms, CT scan rooms, and cath labs by 2024. Additionally, in August 2023, MXR Imaging Inc. acquired Spartan Shielding, bolstering its capabilities in RF, magnetic, and radiation protection for MRI rooms. These advancements, including lead-free materials like tungsten and bismuth alloys, reflect a shift toward safer, lighter, and environmentally friendly shielding solutions.
Market Segmentation
The market is segmented by product type, solution, and end-user. In 2023, the shields segment held a 41.7% market share due to its customizable protection for radiation therapy, as reported by Coherent Market Insights. X-ray shielding dominated in 2023, accounting for 45% of revenue, driven by widespread use in medical imaging, while MRI shielding is the fastest-growing segment due to increasing demand for advanced MRI technologies. Diagnostic shielding led the solution segment in 2023, but radiation therapy shielding is expected to grow rapidly, fueled by rising cancer treatments. Hospitals and diagnostic centers held the largest end-user share in 2023, with research institutes poised for significant growth.
Regional Insights
North America accounted for 37.09% of the market in 2023, driven by advanced healthcare infrastructure, high cancer prevalence, and stringent safety regulations. The U.S. performed over 80 million CT scans in 2023, necessitating robust shielding solutions. Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure investments in countries like China and India, where cancer incidence is projected to rise by 12.8% by 2025, according to the NIH.
Market Challenges
High costs of advanced shielding materials and R&D, coupled with a shortage of skilled radiologists and oncologists, pose challenges. Regulatory compliance and the environmental concerns of lead-based shielding also necessitate ongoing innovation in non-toxic alternatives.
Conclusion
The medical radiation shielding market is set to grow from USD 1.51 billion in 2024 to USD 2.5 billion by 2032, at a CAGR of 6.52%, driven by rising chronic disease prevalence, diagnostic imaging growth, and occupational safety concerns. Innovations in lead-free and lightweight shielding solutions, alongside regional healthcare investments, are key growth catalysts. However, high costs and regulatory challenges require strategic advancements to sustain market momentum.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation